We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GNK:NYSEGenco Shipping & Trading Limited Analysis

Data as of 2026-06-30 - not real-time

$24.39

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

GNK is trading just above its 20‑day and 50‑day simple moving averages, with the price sitting near the midpoint of a well‑defined support‑resistance band. The RSI hovers around the neutral 50‑mark and the MACD histogram has turned positive, indicating modest short‑term momentum, while volume has been on the rise. However, the stock’s trailing P/E of over 60 is more than double the industry average and the DCF‑derived fair value sits near $20, implying the market is pricing in a premium. The 30‑day volatility exceeds 30 % and beta under 1 suggest a stock that can swing sharply but is less correlated with broader market moves.
Fundamentally, GNK delivers strong revenue growth of roughly 60 % year‑over‑year but profit margins remain thin and free cash flow is deeply negative, compounded by a debt‑to‑equity ratio above 30. The dividend yield appears attractive at nearly 5 % but the payout ratio exceeds 200 %, raising doubts about sustainability. The most material catalyst is Diana Shipping’s revised takeover proposal at $27.34 per share, which represents a premium to the current price and has already attracted a sizable tender offer, creating upside potential if the deal closes. Investors must weigh this acquisition premium against the underlying operational weaknesses and high valuation multiples.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Pending takeover premium from Diana Shipping
  • Positive short‑term technical momentum
  • Increasing trading volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Uncertainty around shareholder approval of the acquisition
  • High valuation relative to DCF and peers
  • Weak cash‑flow generation and high leverage

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Sustained overvaluation if acquisition does not materialize
  • Thin profit margins and negative free cash flow
  • Elevated debt levels and dividend sustainability concerns

Key Metrics & Analysis

Financial Health

Revenue Growth60.60%
Profit Margin4.38%
P/E Ratio62.5
ROE1.90%
ROA1.83%
Debt/Equity36.58
P/B Ratio1.2
Op. Cash Flow$44.7M
Free Cash Flow$-139764992
Industry P/E31.7

Technical Analysis

TrendNeutral
RSI53.6
Support$22.93
Resistance$25.27
MA 20$23.93
MA 50$24.22
MA 200$20.80
MACDBullish
VolumeIncreasing
Fear & Greed Index89.91

Valuation

Fair Value$20.10
Target Price$29.25
Upside/Downside19.93%
GradeOvervalued
TypeBlend
Dividend Yield4.72%

Risk Assessment

Beta0.89
Volatility32.09%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.